Evaluation of the rapid diagnostic test OptiMAL for diagnosis of malaria due to Plasmodium vivax.

Cayetano Heredia University, Institute of Tropical Medecine Alexander von Humboldt, Lima, Peru.
Brazilian Journal of Infectious Diseases (Impact Factor: 1.04). 05/2004; 8(2):151-5. DOI: 10.1590/S1413-86702004000200005
Source: PubMed

ABSTRACT To determine the sensitivity and specificity of the rapid diagnostic test OptiMAL for diagnosis of Plasmodium vivax malaria.
We included all the patients who sought medical attention in the San Martin Pangoa Hospital, Junin, an area endemic for vivax malaria in Peru, between October and December 1998, who had fever during the previous 72 hours and who were older than 12 months. The gold standard for diagnosis was thick blood film microscopy. We determined the parasitemia rate for each of the positive slides. We calculated sensitivity, specificity, positive predictive value and negative predictive value of the test.
We included 72 patients; 39 of them were positive for P. vivax by microscopic examination. The sensitivity of the Optimal test was 92.3%, the specificity 100%, the positive predictive value 100% and the negative predictive value 91.6%. The accuracy of the test was 95.8%. The sensitivity of the OptiMAL test progressively decreased when parasitemia was lower than 1,000 parasites/microliter.
the OptiMAL test has a high sensitivity and specificity for diagnosis of P. vivax malaria. However, its sensitivity decreased when parasitemia levels were lower. It is a very simple technique, which makes it a good alternative for malaria diagnosis in remote places, although its elevated cost is still a problem.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the cost-effectiveness ratios of three options for diagnosing malaria at the local health provider in 50 communities near the Peruvian Amazon. Calculation of the incremental cost-effectiveness ratios of three options for diagnosing malaria-not using rapid tests, using rapid tests, and accessing microscopy-in patients presenting with fever in 50 communities near Iquitos in the Peruvian Amazon, communities with limited access to microscopy that depend on a network of local health providers. The incremental costs and effects of the two latter options were calculated and compared with the first option (currently in use). By dividing the incremental costs among the incremental effects, the incremental cost-effectiveness ratio was calculated. Using rapid tests would save the Ministry of Health of Peru: US$191 for each new case of Plasmodium falciparum malaria treated promptly and appropriately; US$31 per new case of P. vivax malaria treated promptly and appropriately; US$1,051 per case of acute malaria averted; and US$17,655 for each death avoided. Access to microscopy by all the communities would generate an additional cost of: US$198 per new case of P. falciparum malaria treated promptly and appropriately; US$31 per new case of P. vivax malaria treated promptly and appropriately; US$1,086 per case of acute malaria averted; and US$18,255 for each death avoided. The use of rapid tests by local health providers can improve the effectiveness of malaria diagnosis in patients with fever in the 50 communities studied, at a cost lower than the current method. The recommendation is to expand the use of rapid tests among the health providers in communities similar to those studied.
    Revista Panamericana de Salud Pública 06/2009; 25(5):377-88. · 0.85 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Malaria remains one of the most important endemic disease threats facing the Canadian Forces during overseas deployment. The existing accepted gold-standard for diagnosing malaria is the microscopic examination of thick and thin blood smears. This method has the advantage of high sensitivity, quantifiable results, and accurate speciation, but is fairly time-consuming and requires well-trained microscopists in order to detect low parasitemias and to properly differentiate the species. Commercially available rapid diagnostic immunocapture test strips now exist which do not require the same level of training and equipment as microscopic examination, and are also significantly faster. However, as this review delineates, clinical trials have shown that the strips are not as sensitive as microscopic examination in detecting low level parasitemias, cannot quantify the level of malaria infection, and, at present, can only differentiate between falciparum and non-falciparum malaria. The strips also have problems relating to antigen persistence in the blood after parasite clearance from chemotherapy, leading to false positive post-therapeutic diagnoses. At present, the test strips are not approved by Health Canada and any use must be under appropriate clinical trial conditions. In addition, the test strips are currently not recommended to be used without a parallel blood smear sample being examined.
  • Source
    Acta Cientifica Estudiantil. 01/2005; 3(3):78-83.


Available from